Dynegy Inc. (DYN): Price and Financial Metrics Recent IPO

Dynegy Inc. (DYN) Recent IPO

Today's Latest Price: $18.16 USD

0.57 (3.24%)

Updated Oct 27 4:00pm

Add DYN to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

See all "A" rated Strong Buy stocks

DYN Stock Price Chart Interactive Chart >

Price chart for DYN

DYN Price/Volume Stats

Current price $18.16 52-week high $27.11
Prev. close $17.59 52-week low $15.60
Day low $17.46 Volume 257,300
Day high $19.30 Avg. volume 244,700
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap 791.50M

Dynegy Inc. (DYN) Company Bio

Dynegy Inc. produces and sells electric energy, capacity, and ancillary services in the United States. It operates in three segments, Coal, IPH, and Gas. The company was founded in 1984 and is based in Houston, Texas.

DYN Latest News Stream

Event/Time News Detail
Loading, please wait...

DYN Latest Social Stream

Loading social stream, please wait...

View Full DYN Social Stream

Latest DYN News From Around the Web

Below are the latest news stories about Dyne Therapeutics Inc that investors may wish to consider to help them evaluate DYN as an investment opportunity.

Dyne Therapeutics prices upsized IPO above range at $19

A muscle disease company, Dyne Therapeutics (DYN) has priced its IPO of 12,251,578 common shares at $19.00/share, for expected gross proceeds of ~$233M.Trading kicks off September 17.The company initially planned to sell 10.3M shares at a price $16-18.Underwriters' over-allotment is an additional 1,837,736 shares. Closing date is September 21.Previously: Dyne Therapeutics...

Seeking Alpha | September 17, 2020

IPO Update: Dyne Therapeutics Readies $175 Million IPO

Quick Take Dyne Therapeutics (DYN) intends to raise $175 million from the sale of its common stock in an IPO, according to an amended registration statement. The company is a pre-clinical stage developer of treatment candidates for various serious muscle diseases. Dyne hasn’t entered Phase 1 safety trials yet, so...

Donovan Jones on Seeking Alpha | September 13, 2020

Read More 'DYN' Stories Here

DYN Price Returns

1-mo -15.53%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6884 seconds.